Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril
- PMID: 3885981
- PMCID: PMC481784
- DOI: 10.1136/hrt.53.4.431
Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril
Abstract
The contribution of the renin-angiotensin system to the cardiovascular response to exercise was studied in 12 patients with congestive heart failure. The haemodynamic effects of captopril were measured at rest and during supine bicycle exercise. After captopril administration, resting systemic vascular resistance fell by 26.6% and mean blood pressure by 16.7% and cardiac index increased by 19.7%. During exercise, captopril decreased systemic vascular resistance by 25.6% and mean blood pressure by 8.2% and increased cardiac index by 24.4%. Pulmonary wedge pressure fell by 25% at rest but was not altered by captopril during exercise. Pretreatment plasma renin activity increased from 13.4(16.0) ng/ml/hr (10.3(12.3) mmol/l/hr) at rest to 20.0(27.8) ng/ml/hr (15.4(21.4) mmol/l/hr) during exercise. Pretreatment plasma noradrenaline concentration increased from 659(433) pg/ml (39(25.6) nmol/l) at rest to 2622(1486) pg/ml during exercise (155(88) nmol/l). Captopril favourably alters systemic vascular resistance and cardiac index during exercise in patients with congestive heart failure. This may reflect inhibition of the increased activity of the renin-angiotensin system during exercise in these patients and a subsequent reduction in systemic vasoconstriction.
Similar articles
-
The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).Am J Cardiol. 1982 May;49(7):1667-74. doi: 10.1016/0002-9149(82)90244-2. Am J Cardiol. 1982. PMID: 7044087
-
Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.Am Heart J. 1981 May;101(5):548-56. doi: 10.1016/0002-8703(81)90220-9. Am Heart J. 1981. PMID: 7013458
-
Hemodynamic and regional blood flow response to captopril in congestive heart failure.Am J Med. 1984 May 31;76(5B):38-42. doi: 10.1016/0002-9343(84)90881-7. Am J Med. 1984. PMID: 6375361
-
Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.Drugs. 1984 Aug;28(2):144-69. doi: 10.2165/00003495-198428020-00004. Drugs. 1984. PMID: 6205842 Review.
-
[Captopril in congestive heart failure (author's transl)].Klin Wochenschr. 1982 Feb 1;60(3):107-13. doi: 10.1007/BF01711274. Klin Wochenschr. 1982. PMID: 6210798 Review. German.
Cited by
-
A randomized cross-over study of enalapril in congestive heart failure: haemodynamic and hormonal effects during rest and exercise.Eur J Clin Pharmacol. 1988;34(4):323-31. doi: 10.1007/BF00542431. Eur J Clin Pharmacol. 1988. PMID: 2841136 Clinical Trial.
-
The I1-imidazoline agonist moxonidine decreases sympathetic tone under physical and mental stress.Br J Clin Pharmacol. 2004 May;57(5):545-51. doi: 10.1111/j.1365-2125.2003.02058.x. Br J Clin Pharmacol. 2004. PMID: 15089806 Free PMC article. Clinical Trial.
-
Novel drugs and current therapeutic approaches in the treatment of heart failure.Drugs. 1996 Mar;51(3):347-58. doi: 10.2165/00003495-199651030-00001. Drugs. 1996. PMID: 8882374 Review.
-
Enalapril reduces the catecholamine response to exercise in patients with heart failure.Eur J Clin Pharmacol. 1986;30(4):485-7. doi: 10.1007/BF00607965. Eur J Clin Pharmacol. 1986. PMID: 3017723 Clinical Trial.
-
Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.Drugs. 1988 Nov;36(5):540-600. doi: 10.2165/00003495-198836050-00003. Drugs. 1988. PMID: 3063499 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical